Randy Milby - 06 Jun 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Issuer symbol
THAR
Transactions as of
06 Jun 2022
Net transactions value
+$688
Form type
4
Filing time
07 Jun 2022, 16:15:57 UTC
Previous filing
02 Jun 2022
Next filing
21 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Purchase $160 +234 +0.01% $0.6849 2,937,774 06 Jun 2022 Direct
transaction HILS Common Stock Purchase $67.01 +100 +0% $0.6701 2,937,874 06 Jun 2022 Direct
transaction HILS Common Stock Purchase $67.01 +100 +0% $0.6701 2,937,974 06 Jun 2022 Direct
transaction HILS Common Stock Purchase $44.23 +66 +0% $0.6701 2,938,040 06 Jun 2022 Direct
transaction HILS Common Stock Purchase $350 +500 +0.02% $0.6999 2,938,540 06 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.